A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a ...

Investigators at CHOP and UPenn found that lower cell counts could still be associated with poor outcomes if the cells were ...

Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...

DelveInsight's Orphan Drugs Market Insights report provides the current and forecast market analysis, individual leading ...

Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine ...

Advocates stress that while gene therapy is causing a buzz in wealthy countries, African governments must prioritise ...

Finding out how microbes make compounds containing the diazo chemical group could help researchers to synthesize useful ...

Cambridge, Massachusetts Wednesday, March 4, 2026, 18:00 Hrs [IST] ...

Glycosylation research is steadily emerging as a critical area in the field of tumor immunology, offering fresh insights into how cancers subvert immune ...

Intellia is now able to continue both Phase III trials of nex-z. Credit: Piotr Swat / Shutterstock.com (Piotr Swat / ...

This manuscript describing the phenotypes associated with loss and gain of RVCL-S documents important findings that have practical implications. Although the data and methods are solid and support ...

Exploring the promising potential and challenges of organoids in esophagus and esophageal squamous cell carcinoma research ...